James B. Renacci bought Pacira BioSciences, Inc. (NASDAQ: PCRX)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 6 trades in Pacira BioSciences, Inc. (PCRX) since 2015, 5 purchases and 1 sale, worth an estimated $146K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $1,001 - $15,000 of Pacira BioSciences, Inc. (NASDAQ: PCRX) on December 13, 2016. Since that trade, PCRX is down -16.67% against the S&P 500 up +273.15%, an outperformance of -289.82%.
Across these filings, James B. Renacci has been a net buyer of PCRX (a buy-to-sell ratio of 5.00). The most recent disclosed PCRX transaction shown was dated January 13, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's PCRX trades vs the price
PCRX is down -16.67% since James B. Renacci bought on December 13, 2016, versus +273.15% for the S&P 500.
Performance since this trade
All James B. Renacci PCRX trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & PCRX trading FAQ
Is it legal for James B. Renacci to trade Pacira BioSciences, Inc. (PCRX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Pacira BioSciences, Inc. (PCRX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy PCRX?
James B. Renacci disclosed a purchase of $1,001 - $15,000 of Pacira BioSciences, Inc. (PCRX) on December 13, 2016, according to public STOCK Act filings.
How has PCRX performed since James B. Renacci's trade?
Since James B. Renacci bought PCRX on December 13, 2016, the stock is down -16.67%, versus +273.15% for the S&P 500 over the same period, an outperformance of -289.82%.
How many times has James B. Renacci traded PCRX?
James B. Renacci has disclosed 6 PCRX trades since 2015 (5 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional PCRX trades?
Quantellect tracks every disclosed congressional trade in Pacira BioSciences, Inc. (PCRX) on the Pacira BioSciences, Inc. congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's PCRX tradesAll congressional filings for Pacira BioSciences, Inc.James B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.